205 related articles for article (PubMed ID: 30132130)
1. CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas.
Lawlor RT; Daprà V; Girolami I; Pea A; Pilati C; Nottegar A; Piccoli P; Parolini C; Sperandio N; Capelli P; Scarpa A; Luchini C
Virchows Arch; 2019 Jan; 474(1):105-109. PubMed ID: 30132130
[TBL] [Abstract][Full Text] [Related]
2. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic Utility of LEF1 Immunostain in Cytology Specimens of Solid Pseudopapillary Neoplasm of Pancreas].
Farzaneh T; Nowroozizadeh B; Han M; Lee W
Acta Cytol; 2021; 65(3):250-256. PubMed ID: 33887729
[TBL] [Abstract][Full Text] [Related]
4. Nonductal Pancreatic Cancers.
Jun SY; Hong SM
Surg Pathol Clin; 2016 Dec; 9(4):581-593. PubMed ID: 27926361
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating neutrophils in pancreatic neoplasia.
Reid MD; Basturk O; Thirabanjasak D; Hruban RH; Klimstra DS; Bagci P; Altinel D; Adsay V
Mod Pathol; 2011 Dec; 24(12):1612-9. PubMed ID: 21822201
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
[TBL] [Abstract][Full Text] [Related]
7. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of solid pseudopapillary tumors of the pancreas: the expression pattern of CD99 is highly unique.
Li L; Li J; Hao C; Zhang C; Mu K; Wang Y; Zhang T
Cancer Lett; 2011 Nov; 310(1):9-14. PubMed ID: 21775056
[TBL] [Abstract][Full Text] [Related]
9. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.
Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC
Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515
[TBL] [Abstract][Full Text] [Related]
10. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms.
Shroff S; Rashid A; Wang H; Katz MH; Abbruzzese JL; Fleming JB; Wang H
Hum Pathol; 2014 Mar; 45(3):456-63. PubMed ID: 24418153
[TBL] [Abstract][Full Text] [Related]
11. Non-Ductal Tumors of the Pancreas.
Dhillon J
Monogr Clin Cytol; 2020; 26():92-108. PubMed ID: 32987393
[TBL] [Abstract][Full Text] [Related]
12. Solid-pseudopapillary neoplasms of the pancreas in men and women: do they differ?
Takahashi Y; Hiraoka N; Onozato K; Shibata T; Kosuge T; Nimura Y; Kanai Y; Hirohashi S
Virchows Arch; 2006 May; 448(5):561-9. PubMed ID: 16523258
[TBL] [Abstract][Full Text] [Related]
13. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.
Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV; Hruban RH
Mod Pathol; 2005 Jun; 18(6):752-61. PubMed ID: 15696124
[TBL] [Abstract][Full Text] [Related]
14. ABCD1 as a Novel Diagnostic Marker for Solid Pseudopapillary Neoplasm of the Pancreas.
Liu YA; Liu Y; Tu J; Shi Y; Pang J; Huang Q; Wang X; Lin Z; Zhao Y; Wang W; Peng J; Wu W
Am J Surg Pathol; 2024 May; 48(5):511-520. PubMed ID: 38567813
[TBL] [Abstract][Full Text] [Related]
15. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.
Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S
Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097
[TBL] [Abstract][Full Text] [Related]
16. Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis.
Meriden Z; Shi C; Edil BH; Ellison T; Wolfgang CL; Cornish TC; Schulick RD; Hruban RH
Am J Surg Pathol; 2011 Jul; 35(7):981-8. PubMed ID: 21677537
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SOX11 and TFE3 in Solid-Pseudopapillary Neoplasms of the Pancreas.
Harrison G; Hemmerich A; Guy C; Perkinson K; Fleming D; McCall S; Cardona D; Zhang X
Am J Clin Pathol; 2017 Dec; 149(1):67-75. PubMed ID: 29272888
[TBL] [Abstract][Full Text] [Related]
19. Can solid pseudopapillary neoplasm of the pancreas without degeneration be diagnosed with imaging? a comparison study of the solid component of solid pseudopapillary neoplasm, neuroendocrine neoplasm, and ductal adenocarcinoma.
Toshima F; Inoue D; Kozaka K; Komori T; Takamatsu A; Katagiri A; Gabata T
Abdom Radiol (NY); 2023 Mar; 48(3):936-951. PubMed ID: 36708377
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis.
Ohara Y; Oda T; Hashimoto S; Akashi Y; Miyamoto R; Enomoto T; Satomi K; Morishita Y; Ohkohchi N
World J Gastroenterol; 2016 Oct; 22(38):8596-8604. PubMed ID: 27784972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
